# Yiyao Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yiyao-technology

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Website: www.gigaceuticals.com
- Total disclosed funding: $1.6M
- Latest round: Angel (Mar 15, 2022)
- Investors on record: 3

## About

Established in 2018 and based in Beijing, China, Yiyao Technology operates as a Technology is a pharmaceutical company that focuses on developing medicine via utilizing artificial intelligence technology. As of 2022, the company raised financial from Powercloud, and Innovation Angel Funds.

The company's AI systems can be categorized into Deep Learning based Efficacy Prediction System (DLEPS), Ligand Ensembles based Small Molecules’ Design, Intelligent Docking System driven by Reinforcement Learning, and Retrosynthesis Prediction System for Natural Products. DLEPS can be used to find novel targets for diseases by finding the compound first, then studying their MOA. The overall accuracy of DLEPS at the animal level is around 60%.

## Funding rounds

- Angel, Mar 15, 2022, $1.6M — Sangel Capital
- Angel, Sep 16, 2018 — Powercloud, Innoangel Fund

## Investors

- Powercloud (https://capitalatlas.ai/funds/powercloud) — Angel
- Innoangel Fund (https://capitalatlas.ai/funds/innoangel-fund) — Angel
- Sangel Capital (https://capitalatlas.ai/funds/sangel-capital) — Angel